Successful Rituximab Treatment for Lymphoma, Secondary Immunodeficiency Causing Debilitating Sinusitis: Underlying Primary Immunodeficiency Disease, and Alternative Treatments to Improve the Quality of Life?

J Clin Immunol. 2019 Apr;39(3):229-230. doi: 10.1007/s10875-019-00636-1. Epub 2019 May 17.

Author

Vincent R Bonagura¹

Affiliation

¹ Chief, Division of Allergy/Immunology, Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA. VBonagura@northwell.edu.

PMID: 31102034
DOI: 10.1007/s10875-019-00636-1

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents, Immunological / therapeutic use*
Humans
Immunologic Deficiency Syndromes / immunology
Immunologic Deficiency Syndromes / therapy*
Lymphoma / immunology
Lymphoma / therapy*
Primary Immunodeficiency Diseases / immunology
Primary Immunodeficiency Diseases / therapy*
Quality of Life
Rituximab / therapeutic use*
Sinusitis / immunology
Sinusitis / therapy*

Substances

Antineoplastic Agents, Immunological
Rituximab